2026. Baseline Characteristics in Patients with Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy). SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s734. DOI:https://doi.org/10.25251/djee0862.